197 related articles for article (PubMed ID: 2842274)
1. Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.
Sculley TB; Sculley DG; Pope JH; Bornkamm GW; Lenoir GM; Rickinson AB
Intervirology; 1988; 29(2):77-85. PubMed ID: 2842274
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
3. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
4. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
6. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
[TBL] [Abstract][Full Text] [Related]
8. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
[TBL] [Abstract][Full Text] [Related]
9. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
10. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
11. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.
Sculley TB; Cross SM; Borrow P; Cooper DA
J Infect Dis; 1988 Jul; 158(1):186-92. PubMed ID: 2839581
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.
Kaymaz Y; Oduor CI; Aydemir O; Luftig MA; Otieno JA; Ong'echa JM; Bailey JA; Moormann AM
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581102
[TBL] [Abstract][Full Text] [Related]
16. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults.
Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
Dambaugh T; Wang F; Hennessy K; Woodland E; Rickinson A; Kieff E
J Virol; 1986 Aug; 59(2):453-62. PubMed ID: 2426468
[TBL] [Abstract][Full Text] [Related]
19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
20. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]